HomeCompareABDDF vs MRK

ABDDF vs MRK: Dividend Comparison 2026

ABDDF yields 0.73% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABDDF wins by $150.8K in total portfolio value· pulled ahead in Year 7
10 years
ABDDF
ABDDF
● Live price
0.73%
Share price
$16.80
Annual div
$0.12
5Y div CAGR
79.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$208.5K
Annual income
$116,645.77
Full ABDDF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — ABDDF vs MRK

📍 ABDDF pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABDDFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABDDF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ABDDF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABDDF
Annual income on $10K today (after 15% tax)
$62.18/yr
After 10yr DRIP, annual income (after tax)
$99,148.90/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, ABDDF beats the other by $90,552.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABDDF + MRK for your $10,000?

ABDDF: 50%MRK: 50%
100% MRK50/50100% ABDDF
Portfolio after 10yr
$133.1K
Annual income
$63,379.78/yr
Blended yield
47.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ABDDF
No analyst data
Altman Z
5.8
Piotroski
7/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABDDF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABDDFMRK
Forward yield0.73%2.81%
Annual dividend / share$0.12$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR79.2%32.7%
Portfolio after 10y$208.5K$57.7K
Annual income after 10y$116,645.77$10,113.78
Total dividends collected$180.3K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ABDDF vs MRK ($10,000, DRIP)

YearABDDF PortfolioABDDF Income/yrMRK PortfolioMRK Income/yrGap
1$10,831$131.09$11,213$373.04$382.00MRK
2$11,827$237.80$12,667$512.06$840.00MRK
3$13,090$434.88$14,439$708.14$1.3KMRK
4$14,812$806.08$16,640$988.16$1.8KMRK
5$17,377$1,527.63$19,432$1,394.07$2.1KMRK
6$21,594$3,001.36$23,057$1,992.90$1.5KMRK
7← crossover$29,353$6,246.65$27,889$2,894.79+$1.5KABDDF
8$45,628$14,220.28$34,518$4,286.29+$11.1KABDDF
9$85,842$37,020.52$43,912$6,494.35+$41.9KABDDF
10$208,497$116,645.77$57,714$10,113.78+$150.8KABDDF

ABDDF vs MRK: Complete Analysis 2026

ABDDFStock

AB Dynamics plc, through its subsidiaries, engages in the design, development, manufacture, and supply of vehicle test and development systems, and verification products and services for advanced driver assistance systems (ADAS), autonomous vehicle technology, and vehicle dynamics in the United Kingdom, Germany, the United States of America, China, Japan, Singapore, and internationally. The company offers advanced vehicle testing solutions from physical proving ground automation to large scale virtual testing in simulation; rFpro, a simulation environment for the automotive and motorsport industries; and full-scale track testing services, including ADAS and vehicle dynamics tests, along with applied research, human factors, and simulation. It also provides automotive testing services comprising evaluations of ADAS systems, infotainment, connectivity, electric vehicle performance and charging, and other associated functions; and retrofit solutions that enable the automation of conventional vehicle fleets rapidly and cost-effectively. In addition, the company creates and deploys a range of Driver-in-the-Loop (DIL) simulators for all types of vehicles, driving scenarios, experiments, and product development aims; supplies end-to-end simulation solutions, such as hardware, software, application consultancy, training, and aftermarket support; and advanced vehicle testing solutions from physical proving ground automation to virtual testing in simulation. Its products are used to evaluate vehicle dynamics, noise, vibration, and harshness and autonomy for a range of applications comprise conventional vehicles, motorsport, and automated/autonomous vehicles. The company was founded in 1982 and is headquartered in Bradford-on-Avon, the United Kingdom.

Full ABDDF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ABDDF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABDDF vs SCHDABDDF vs JEPIABDDF vs OABDDF vs KOABDDF vs MAINABDDF vs JNJABDDF vs ABBVABDDF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.